Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 039421/0288 | |
| Pages: | 6 |
| | Recorded: | 07/21/2016 | | |
| Attorney Dkt #: | P66015IM14 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAMES ON COVERSHEET PREVIOUSLY RECORDED ON REEL 036499 FRAME 0057. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14846474
|
Filing Dt:
|
09/04/2015
|
|
Publication #:
|
|
Pub Dt:
|
03/10/2016
| | | | |
|
Title:
|
Development of Protein-Based Biotherapeutics That Penetrate Cell-Membrane and Induce Anti-Cancer Effect- Cell-Permeable Glutathione Peroxidase7 (CP-GPX7) in Gastrointestinal Track (GIT), Polynucleotides Encoding the Same, and Anti-Cancer Compositions Comprising the Same
|
|
|
Assignees
|
|
|
|
|
| 2319 TINNEY PLACE |
| BRENTWOOD, TENNESSEE 37207 |
|
|
|
|
|
| 9TH FLOOR, 189 SUNGAM-RO, MAPO-GU |
| SEOUL, KOREA, REPUBLIC OF 121-830 |
|
|
Correspondence name and address
|
| |
THE PL LAW GROUP, PLLC
|
| |
5875 TRINITY PARKWAY, SUITE 110
|
| |
CENTREVILLE, VA 20120
|
Search Results as of:
06/26/2025 06:43 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
